ObjectiveTo compare the effects of extended- versus short-time
noninvasive positive pressure ventilation on pulmonary function, tissue
perfusion, and clinical outcomes in the early postoperative period following
coronary artery bypass surgery in patients with preserved left ventricular
function.MethodsPatients were randomized into two groups according to noninvasive positive
pressure ventilation intensity: short-time noninvasive positive pressure
ventilation n=20 (S-NPPV) and extended-time noninvasive positive pressure
ventilation n=21 (E-NPPV). S-NPPV was applied for 60 minutes during
immediate postoperative period and 10 minutes, twice daily, from
postoperative days 1-5. E-NPPV was performed for at least six hours during
immediate postoperative period and 60 minutes, twice daily, from
postoperative days 1-5. As a primary outcome, tissue perfusion was
determined by central venous oxygen saturation and blood lactate level
measured after anesthetic induction, immediately after extubation and
following noninvasive positive pressure ventilation protocols. As a
secondary outcome, pulmonary function tests were performed preoperatively
and in the postoperative days 1, 3, and 5; clinical outcomes were recorded.
ResultsSignificant drop in blood lactate levels and an improvement in central venous
oxygen saturation values in the E-NPPV group were observed when compared
with S-NPPV group after study protocol (P<0.01). The
E-NPPV group presented higher preservation of postoperative pulmonary
function as well as lower incidence of respiratory events and shorter
postoperative hospital stay (P<0.05).ConclusionProphylactic E-NPPV administered in the early postoperative period of
coronary artery bypass surgery resulted in greater improvements in tissue
perfusion, pulmonary function and clinical outcomes than S-NPPV, in patients
with preserved left ventricular function.Trial RegistrationBrazilian Registry of Clinical trial - RBR7sqj78 - http://www.ensaiosclinicos.gov.br
ObjectiveTo compare pulmonary function, functional capacity and clinical outcomes
amongst three groups of patients with left ventricular dysfunction following
off-pump coronary artery bypass, namely: 1) conventional mechanical
ventilation (CMV); 2) late open lung strategy (L-OLS); and 3) early open
lung strategy (E-OLS).MethodsSixty-one patients were randomized into 3 groups: 1) CMV (n=21); 2) L-OLS
(n=20) initiated after intensive care unit arrival; and 3) E-OLS (n=20)
initiated after intubation. Spirometry was performed at bedside on
preoperative and postoperative days (PODs) 1, 3, and 5. Partial pressure of
arterial oxygen (PaO2) and pulmonary shunt fraction were
evaluated preoperatively and on POD1. The 6-minute walk test was applied on
the day before the operation and on POD5.ResultsBoth the open lung groups demonstrated higher forced vital capacity and
forced expiratory volume in 1 second on PODs 1, 3 and 5 when compared to the
CMV group (P<0.05). The 6-minute walk test distance was
more preserved, shunt fraction was lower, and PaO2 was higher in
both open-lung groups (P<0.05). Open-lung groups had
shorter intubation time and hospital stay and also fewer respiratory events
(P<0.05). Key measures were significantly more
favorable in the E-OLS group compared to the L-OLS group.ConclusionBoth OLSs (L-OLS and E-OLS) were able to promote higher preservation of
pulmonary function, greater recovery of functional capacity and better
clinical outcomes following off-pump coronary artery bypass when compared to
conventional mechanical ventilation. However, in this group of patients with
reduced left ventricular function, initiation of the OLS intra-operatively
was found to be more beneficial and optimal when compared to OLS initiation
after intensive care unit arrival.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.